Sat, Jan 31, 2015, 12:43 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Elan Corporation, plc Message Board

  • drhollars drhollars Apr 5, 2005 11:03 AM Flag

    ELN to file Ch.11

     

    soon

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • drhollare

      People like you -- who insinuate false rumors should be banned from posting such nonsense on message boards!

      Where the hell is yahoo on this crap? -- you are one sick mother -- I hope you get sued by ELN!

    • Kinda hard don't you think, since they are an Irish company and Ireland does not have a Chapter 11?

      Their US sub coud do so I guess, just like the KKD sub in Canada filed for protection there, but please understand bk law before you make such a foolish comment.

    • not that I am a legal specialist, but tabloids are different than writing BS about a stock.

    • AVN...PRIORITY REVIEW- GRANTED BY THE FDA!!

      Breaking news just out & over the wire!!!


      No wonder the short bashers are in a nervouse frenzy!!!

      AVN's potential multi-billion dollar blockuster drug, Neurodex...PRIORITY REVIEW- GRANTED BY THE FDA!!!

      LOAD UP!!!! The shares are still way cheap!!!



      "The FDA has granted AVANIR's NDA a Priority Review, which is an accelerated six-month review timeline."
      Business Wire

      ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
      Insider Buying / * AVN CEO Aquires 2M Shares*~
      This is extremely BULLISH and the short bashers are in a nervous frenzy!
      ~~~STRONG BUY~~~

      YAKATAN, GERALD J.: Declared Holdings
      Company/Relationship Reported Shares Ownership
      AVANIR PHARMACEUTICL
      Chief Executive Officer
      AMEX:AVN

      8-Mar-05 2,000,000 AVN Acquisition (Non Open Market) at $2.65 per
      share.
      (Value of $5,300,000)

      Also, biotech guru, Jonathan Silverman recently did a private purchase of 900,000 shares bring him in control of 8,775,000 shares.

      Avanir Pharmaceuticals, symbol AVN, Potential multi-billion dollar
      blockbuster drug in Phase 3 with remarkable results up for FDA
      Priority Approval, fantastic Anthrax Antibody, unique Cancer
      Compound unlike anything ever seen before, IgE for allergies and
      asthma, Abreva herpes cream worldwide, unique Stem Cell patent, anti-
      cholestoral drug, Xenerex subsidiary for the production of the only
      completely human mABs.

    • honeybunny6969honeybunny honeybunny6969honeybunny Apr 21, 2005 10:00 AM Flag

      AVN...PRIORITY REVIEW- GRANTED BY THE FDA!!!

      Breaking news just out & over the wire!!!


      No wonder the short bashers are in a nervouse frenzy!!!

      AVN's potential multi-billion dollar blockuster drug, Neurodex...PRIORITY REVIEW- GRANTED BY THE FDA!!!

      LOAD UP!!!! The shares are still way cheap!!!



      "The FDA has granted AVANIR's NDA a Priority Review, which is an accelerated six-month review timeline."
      Business Wire

      ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
      Insider Buying / * AVN CEO Aquires 2M Shares*~
      This is extremely BULLISH and the short bashers are in a nervous frenzy!
      ~~~STRONG BUY~~~

      YAKATAN, GERALD J.: Declared Holdings
      Company/Relationship Reported Shares Ownership
      AVANIR PHARMACEUTICL
      Chief Executive Officer
      AMEX:AVN

      8-Mar-05 2,000,000 AVN Acquisition (Non Open Market) at $2.65 per
      share.
      (Value of $5,300,000)

      Also, biotech guru, Jonathan Silverman recently did a private purchase of 900,000 shares bring him in control of 8,775,000 shares.

      Avanir Pharmaceuticals, symbol AVN, Potential multi-billion dollar
      blockbuster drug in Phase 3 with remarkable results up for FDA
      Priority Approval, fantastic Anthrax Antibody, unique Cancer
      Compound unlike anything ever seen before, IgE for allergies and
      asthma, Abreva herpes cream worldwide, unique Stem Cell patent, anti-
      cholestoral drug, Xenerex subsidiary for the production of the only
      completely human mABs.

    • Chapter 11 of what book? State of Fear? Seriously, why would they do that? They can pay the bills for years.

    • From:

      http://news.yahoo.com/news?tmpl=story&u=/sddt/20050408/lo_sddt/biogenidecsaysnoc
      hangesyetatoceansideplant



      Biogen Idec Inc. says it's business as usual at its new manufacturing plant in Oceanside, even though the drug to be made there was yanked off the market.

      The company is continuing with preparations to begin making the drug Tysabri at the plant next year, said Jose Juves, a spokesman for Biogen Idec (Nasdaq: BIIB). The company is developing the drug with Elan Corp. (NYSE: ELN).

      * * * * *

    • Elan, FTC, SEC, Yahoo all interested in your post.
      I knew they would be so I sent it to them just in case they may have missed it.
      Ashes to ashes and YOU are dust.

    • get a life, before that would ever happen thet would be bought out idiot

      • 6 Replies to jmfreake
      • $500 million in 2006!! This is HUGE!

        AVN...PRIORITY REVIEW- GRANTED BY THE FDA!!!

        AVN's potential multi-billion dollar blockuster drug,

        Neurodex...PRIORITY REVIEW- GRANTED BY THE FDA

        "The FDA has granted AVANIR's NDA a Priority Review, which is an accelerated six-month review timeline."

        Business Wire

        Avanir, with an extremely small overhead, could stand to initially rake in hundreds of millions from Neurodex the first year and billions thereafter if other indications are approved.

        "If approved, Neurodex would be the first drug indicated to treat PBA. In a market survey commissioned by AVANIR, IMS Health estimated the potential market for drugs that treat PBA to be approximately $500 million in 2006, the year in which Neurodex may enter the market if approved by the FDA. Beginning in mid-2005, AVANIR intends to conduct a Phase III clinical trial for the treatment of diabetic neuropathic pain under a Special Protocol Assessment from the FDA."

        Source: Business Wire

        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

        84% Improvement Rate From MS Patients!

        Avanir (AVN) ``Highlight of the Meeting''



        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

        also...

        Insider Buying / * AVN CEO Aquires 2M Shares*~

        This is extremely BULLISH ~~~STRONG BUY~~~

        YAKATAN, GERALD J.: Declared Holdings

        Company/Relationship Reported Shares Ownership

        AVANIR PHARMACEUTICL

        Chief Executive Officer AMEX:AVN 2,000,000 AVN Acquisition (Non Open Market) at $2.65 per share.(Value of $5,300,000) Also, biotech guru, Jonathan Silverstein recently did a private purchase of 900,000 shares bring him in control of 8,775,000 shares.

        Avanir Pharmaceuticals, symbol AVN, Potential multi-billion dollar blockbuster drug in Phase 3 with remarkable results up for FDA Priority Approval, fantastic Anthrax Antibody, unique CancerCompound unlike anything ever seen before, IgE for allergies andasthma, Abreva herpes cream worldwide, unique Stem Cell patent, anti-cholestoral drug, Xenerex subsidiary for the production of the onlycompletely human mABs.



        Shares are under heavy accumulation as reported by MSN...

        AVANIR Pharmaceuticals, a small-cap company in the health care sector, is expected to outperform the market over the next six months with average risk.

        - Shares are under heavy accumulation by financial institutions. Positive for a small company like AVN

        - The StockScouter measure of relative price change and consistency is high. Positive

        Is it worth noting that in the last 3 months AVN has gone from a 2 rating to a 5 rating on the MSN StockScouter measure...I suspect that in the next 3 months AVN will achieve a 7-8 rating (10 is best possible rating) taking this gem to a -significantly outperform the market- with - less than average risk- as institutional/fund ownership increases, fundamentals become increasingly stronger i.e. completed NDA filing/prority review, and who knows what else ...

      • $500 million in 2006!! This is HUGE!

        AVN...PRIORITY REVIEW- GRANTED BY THE FDA!!!
        AVN's potential multi-billion dollar blockuster drug,
        Neurodex...PRIORITY REVIEW- GRANTED BY THE FDA

        "The FDA has granted AVANIR's NDA a Priority Review, which is an
        accelerated six-month review timeline."
        Business Wire

        Avanir, with an extremely small overhead, could stand to initially
        rake in hundreds of millions from Neurodex the first year and
        billions thereafter if other indications are approved.

        "If approved, Neurodex would be the first drug indicated to treat
        PBA. In a market survey commissioned by AVANIR, IMS Health estimated
        the potential market for drugs that treat PBA to be approximately
        $500 million in 2006, the year in which Neurodex may enter the
        market if approved by the FDA. Beginning in mid-2005, AVANIR intends
        to conduct a Phase III clinical trial for the treatment of diabetic
        neuropathic pain under a Special Protocol Assessment from the FDA."

        Source: Business Wire
        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
        84% Improvement Rate From MS Patients!

        Avanir (AVN) ``Highlight of the Meeting''

        www.rednova.com/news/display/?id=143936&source=r_health
        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
        also...
        Insider Buying / * AVN CEO Aquires 2M Shares*~
        This is extremely BULLISH ~~~STRONG BUY~~~

        YAKATAN, GERALD J.: Declared Holdings
        Company/Relationship Reported Shares Ownership
        AVANIR PHARMACEUTICL
        Chief Executive Officer
        AMEX:AVN

        2,000,000 AVN Acquisition (Non Open Market) at $2.65 per
        share.
        (Value of $5,300,000)

        Also, biotech guru, Jonathan Silverman recently did a private
        purchase of 900,000 shares bring him in control of 8,775,000 shares.

        Avanir Pharmaceuticals, symbol AVN, Potential multi-billion dollar
        blockbuster drug in Phase 3 with remarkable results up for FDA
        Priority Approval, fantastic Anthrax Antibody, unique Cancer
        Compound unlike anything ever seen before, IgE for allergies and
        asthma, Abreva herpes cream worldwide, unique Stem Cell patent, anti-

        cholestoral drug, Xenerex subsidiary for the production of the only
        completely human mABs.
        For more info...
        www.avanir.com/
        www.xenerex.com/

      • honeybunny6969honeybunny honeybunny6969honeybunny Apr 25, 2005 5:02 AM Flag

        $500 million in 2006!! This is HUGE!

        AVN...PRIORITY REVIEW- GRANTED BY THE FDA!!!
        AVN's potential multi-billion dollar blockuster drug, Neurodex...PRIORITY REVIEW- GRANTED BY THE FDA

        "The FDA has granted AVANIR's NDA a Priority Review, which is an accelerated six-month review timeline."
        Business Wire

        Avanir, with an extremely small overhead, could stand to initially rake in hundreds of millions from Neurodex the first year and billions thereafter if other indications are approved.
        "If approved, Neurodex would be the first drug indicated to treat
        PBA. In a market survey commissioned by AVANIR, IMS Health estimated
        the potential market for drugs that treat PBA to be approximately
        $500 million in 2006, the year in which Neurodex may enter the
        market if approved by the FDA. Beginning in mid-2005, AVANIR intends
        to conduct a Phase III clinical trial for the treatment of diabetic
        neuropathic pain under a Special Protocol Assessment from the FDA."

        Source: Business Wire
        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
        84% Improvement Rate From MS Patients!

        Avanir (AVN) ``Highlight of the Meeting''

        www.rednova.com/news/display/?id=143936&source=r_health
        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
        also...
        Insider Buying / * AVN CEO Aquires 2M Shares*~
        This is extremely BULLISH ~~~STRONG BUY~~~

        YAKATAN, GERALD J.: Declared Holdings
        Company/Relationship Reported Shares Ownership
        AVANIR PHARMACEUTICL
        Chief Executive Officer
        AMEX:AVN

        2,000,000 AVN Acquisition (Non Open Market) at $2.65 per
        share.
        (Value of $5,300,000)

        Also, biotech guru, Jonathan Silverman recently did a private purchase of 900,000 shares bring him in control of 8,775,000 shares.

        Avanir Pharmaceuticals, symbol AVN, Potential multi-billion dollar
        blockbuster drug in Phase 3 with remarkable results up for FDA
        Priority Approval, fantastic Anthrax Antibody, unique Cancer
        Compound unlike anything ever seen before, IgE for allergies and
        asthma, Abreva herpes cream worldwide, unique Stem Cell patent, anti-cholestoral drug, Xenerex subsidiary for the production of the only
        completely human mABs.

      • AVN...PRIORITY REVIEW- GRANTED BY THE FDA!!!

        Breaking news just out & over the wire!!!


        No wonder the short bashers are in a nervouse frenzy!!!

        AVN's potential multi-billion dollar blockuster drug, Neurodex...PRIORITY REVIEW- GRANTED BY THE FDA!!!

        LOAD UP!!!! The shares are still way cheap!!!


        "The FDA has granted AVANIR's NDA a Priority Review, which is an accelerated six-month review timeline."
        Business Wire

        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
        Insider Buying / * AVN CEO Aquires 2M Shares*~
        This is extremely BULLISH and the short bashers are in a nervous frenzy!
        ~~~STRONG BUY~~~

        YAKATAN, GERALD J.: Declared Holdings
        Company/Relationship Reported Shares Ownership
        AVANIR PHARMACEUTICL
        Chief Executive Officer
        AMEX:AVN

        8-Mar-05 2,000,000 AVN Acquisition (Non Open Market) at $2.65 per
        share.
        (Value of $5,300,000)

        Also, biotech guru, Jonathan Silverman recently did a private purchase of 900,000 shares bring him in control of 8,775,000 shares.

        Avanir Pharmaceuticals, symbol AVN, Potential multi-billion dollar
        blockbuster drug in Phase 3 with remarkable results up for FDA
        Priority Approval, fantastic Anthrax Antibody, unique Cancer
        Compound unlike anything ever seen before, IgE for allergies and
        asthma, Abreva herpes cream worldwide, unique Stem Cell patent, anti-
        cholestoral drug, Xenerex subsidiary for the production of the only
        completely human mABs.

      • when we're done with him

      • Its foolish to talk about Chapter 11.Elan can and will survive,in what form we will know in the next 6 weeks.There is even an outside chance that Elan could reach former heights.We will see.

    • Pat yourself on the back. You've just been added to the litigation list

      • 1 Reply to tumbler478
      • Not too late to swap into AVN and see your dreams through...


        AVN...PRIORITY REVIEW- GRANTED BY THE FDA!!!

        Breaking news just out & over the wire!!!


        No wonder the short bashers are in a nervouse frenzy!!!

        AVN's potential multi-billion dollar blockuster drug, Neurodex...PRIORITY REVIEW- GRANTED BY THE FDA!!!

        LOAD UP!!!! The shares are still way cheap!!!



        "The FDA has granted AVANIR's NDA a Priority Review, which is an accelerated six-month review timeline."
        Business Wire

        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
        Insider Buying / * AVN CEO Aquires 2M Shares*~
        This is extremely BULLISH and the short bashers are in a nervous frenzy!
        ~~~STRONG BUY~~~

        YAKATAN, GERALD J.: Declared Holdings
        Company/Relationship Reported Shares Ownership
        AVANIR PHARMACEUTICL
        Chief Executive Officer
        AMEX:AVN

        8-Mar-05 2,000,000 AVN Acquisition (Non Open Market) at $2.65 per
        share.
        (Value of $5,300,000)

        Also, biotech guru, Jonathan Silverman recently did a private purchase of 900,000 shares bring him in control of 8,775,000 shares.

        Avanir Pharmaceuticals, symbol AVN, Potential multi-billion dollar
        blockbuster drug in Phase 3 with remarkable results up for FDA
        Priority Approval, fantastic Anthrax Antibody, unique Cancer
        Compound unlike anything ever seen before, IgE for allergies and
        asthma, Abreva herpes cream worldwide, unique Stem Cell patent, anti-
        cholestoral drug, Xenerex subsidiary for the production of the only
        completely human mABs.

 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Visa Inc.
NYSEFri, Jan 30, 2015 4:00 PM EST
Amazon.com Inc.
NASDAQFri, Jan 30, 2015 4:00 PM EST